H.C. Wainwright Reiterates Buy Rating, $80 Price Target on Albireo Pharma (ALBO) Jul 7, 2022 06:12AM
Maintain "Confidence Bylvay Could Become the Best-in-Class Agent" - William Blair Reiterates Outperform Rating on Albireo Pharma (ALBO) Jun 8, 2022 05:56AM
H.C. Wainwright Reiterates Buy Rating on Albireo Pharma (ALBO), "We Remain Highly Confident in Bylvay's Likelihood of Success" Mar 29, 2022 11:06AM
William Blair Reiterates Albireo Pharma (ALBO) at Outperform, Bylvay Can Become a Blockbuster in Several Indications Mar 1, 2022 12:24PM
H.C. Wainwright Reiterates Buy Rating on Albireo Pharma (ALBO), Estimates Peak Bylvay PFIC Sales of $446M Feb 23, 2022 07:42AM


Jan 7, 2022 06:46AM Albireo Pharma (ALBO) Bylvay Launch Faster Than Anticipated, Raising Estimates - H.C. Wainwright